Allogene Therapeutics, Inc. (ALLO)
2.48
-0.08
(-3.12%)
USD |
NASDAQ |
Apr 02, 16:00
2.47
-0.01
(-0.40%)
After-Hours: 20:00
Allogene Therapeutics Market Cap : 585.68M for April 2, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| ANI Pharmaceuticals, Inc. | 1.626B |
| Inovio Pharmaceuticals, Inc. | 50.48M |
| Vaxart, Inc. | 142.31M |
| Capricor Therapeutics, Inc. | 1.968B |
| Agenus, Inc. | 125.61M |
Market Cap Related Metrics
| Price to Book Value | 2.067 |
| Price | 2.48 |
| Earnings Yield | -35.01% |